About this Journal Submit a Manuscript Table of Contents
Experimental Diabetes Research
Volume 2012 (2012), Article ID 465282, 8 pages
http://dx.doi.org/10.1155/2012/465282
Research Article

Metformin Stimulates FGF21 Expression in Primary Hepatocytes

1Department of Pharmacology and Pharmacotherapy, University of Copenhagen, 2100 Copenhagen, Denmark
2Department of Diabetes NBEs & Obesity Biology, Novo Nordisk A/S, 2760 Måløv, Denmark
3Department of Incretin Biology, Hagedorn Research Institute, Novo Nordisk A/S, 2820 Gentofte, Denmark

Received 3 August 2012; Accepted 18 September 2012

Academic Editor: Kazuya Yamagata

Copyright © 2012 Eva B. Nygaard et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. K. Badman, P. Pissios, A. R. Kennedy, G. Koukos, J. S. Flier, and E. Maratos-Flier, “Hepatic fibroblast growth factor 21 is regulated by PPARα and is a key mediator of hepatic lipid metabolism in ketotic states,” Cell Metabolism, vol. 5, no. 6, pp. 426–437, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. T. Inagaki, P. Dutchak, G. Zhao et al., “Endocrine regulation of the fasting response by PPARα-mediated induction of fibroblast growth factor 21,” Cell Metabolism, vol. 5, no. 6, pp. 415–425, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Kharitonenkov, T. L. Shiyanova, A. Koester et al., “FGF-21 as a novel metabolic regulator,” Journal of Clinical Investigation, vol. 115, no. 6, pp. 1627–1635, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. K. F. Tacer, A. L. Bookout, X. Ding et al., “Research resource: comprehensive expression atlas of the fibroblast growth factor system in adult mouse,” Molecular Endocrinology, vol. 24, no. 10, pp. 2050–2064, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Iizuka, J. Takeda, and Y. Horikawa, “Glucose induces FGF21 mRNA expression through ChREBP activation in rat hepatocytes,” The FEBS Letters, vol. 583, no. 17, pp. 2882–2886, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Iizuka, J. Takeda, and Y. Horikawa, “Glucose induces FGF21 mRNA expression through ChREBP activation in rat hepatocytes,” The FEBS Letters, vol. 583, no. 17, pp. 2882–2886, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. W. W. Chen, L. Li, G. Y. Yang et al., “Circulating FGF-21 levels in normal subjects and in newly diagnose patients with type 2 diabetes mellitus,” Experimental and Clinical Endocrinology and Diabetes, vol. 116, no. 1, pp. 65–68, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Dushay, P. C. Chui, G. S. Gopalakrishnan et al., “Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease,” Gastroenterology, vol. 139, no. 2, pp. 456–463, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. X. Zhang, D. C. Y. Yeung, M. Karpisek et al., “Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans,” Diabetes, vol. 57, no. 5, pp. 1246–1253, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. C. Gälman, T. Lundåsen, A. Kharitonenkov et al., “The circulating metabolic regulator FGF21 is induced by prolonged fasting and PPARα activation in man,” Cell Metabolism, vol. 8, no. 2, pp. 169–174, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Lundåsen, M. C. Hunt, L. M. Nilsson et al., “PPARα is a key regulator of hepatic FGF21,” Biochemical and Biophysical Research Communications, vol. 360, no. 2, pp. 437–440, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Coskun, H. A. Bina, M. A. Schneider et al., “Fibroblast growth factor 21 corrects obesity in mice,” Endocrinology, vol. 149, no. 12, pp. 6018–6027, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Kharitonenkov, T. L. Shiyanova, A. Koester et al., “FGF-21 as a novel metabolic regulator,” Journal of Clinical Investigation, vol. 115, no. 6, pp. 1627–1635, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Kharitonenkov, V. J. Wroblewski, A. Koester et al., “The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21,” Endocrinology, vol. 148, no. 2, pp. 774–781, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. D. Kirpichnikov, S. I. McFarlane, and J. R. Sowers, “Metformin: an update,” Annals of Internal Medicine, vol. 137, no. 1, pp. 25–33, 2002. View at Scopus
  16. A. Maida, B. J. Lamont, X. Cao, and D. J. Drucker, “Metformin regulates the incretin receptor axis via a pathway dependent on peroxisome proliferator-activated receptor-α in mice,” Diabetologia, vol. 54, no. 2, pp. 339–349, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. M. R. Owen, E. Doran, and A. P. Halestrap, “Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain,” Biochemical Journal, vol. 348, no. 3, pp. 607–614, 2000. View at Publisher · View at Google Scholar · View at Scopus
  18. G. Zhou, R. Myers, Y. Li et al., “Role of AMP-activated protein kinase in mechanism of metformin action,” Journal of Clinical Investigation, vol. 108, no. 8, pp. 1167–1174, 2001. View at Publisher · View at Google Scholar · View at Scopus
  19. B. Andersen, A. Rassov, N. Westergaard, and K. Lundgren, “Inhibition of glycogenolysis in primary rat hepatocytes by 1,4-dideoxy-1,4-imino-D-arabinitol,” Biochemical Journal, vol. 342, no. 3, pp. 545–550, 1999. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Rozen and H. Skaletsky, “Primer3 on the WWW for general users and for biologist programmers,” Methods in Molecular Biology, vol. 132, pp. 365–386, 2000. View at Scopus
  21. M. J. Gómez-Lechón, X. Ponsoda, and J. V. Castell, “A microassay for measuring glycogen in 96-well-cultured cells,” Analytical Biochemistry, vol. 236, no. 2, pp. 296–301, 1996. View at Publisher · View at Google Scholar · View at Scopus
  22. S. A. Hawley, M. Davison, A. Woods et al., “Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase,” Journal of Biological Chemistry, vol. 271, no. 44, pp. 27879–27887, 1996. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Otto, J. Breinholt, and N. Westergaard, “Metformin inhibits glycogen synthesis and gluconeogenesis in cultured rat hepatocytes,” Diabetes, Obesity and Metabolism, vol. 5, no. 3, pp. 189–194, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. M. D. L. Chau, J. Gao, Q. Yang, Z. Wu, and J. Gromada, “Fibroblast growth factor 21 regulates energy metabolism by activating the AMPK-SIRT1-PGC-1α pathway,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 28, pp. 12553–12558, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. E. D. Berglund, L. Kang, R. S. Lee-Young et al., “Glucagon and lipid interactions in the regulation of hepatic AMPK signaling and expression of PPARα and FGF21 transcripts in vivo,” American Journal of Physiology, vol. 299, no. 4, pp. E607–E614, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. H. Tyynismaa, C. J. Carroll, N. Raimundo et al., “Mitochondrial myopathy induces a starvation-like response,” Human Molecular Genetics, vol. 19, no. 20, Article ID ddq310, pp. 3948–3958, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Inagaki, P. Dutchak, G. Zhao et al., “Endocrine regulation of the fasting response by PPARα-mediated induction of fibroblast growth factor 21,” Cell Metabolism, vol. 5, no. 6, pp. 415–425, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. M. J. Potthoff, T. Inagaki, S. Satapati et al., “FGF21 induces PGC-1α and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 26, pp. 10853–10858, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. P. A. Dutchak, T. Katafuchi, A. L. Bookout et al., “Fibroblast growth factor-21 regulates PPARgamma activity and the antidiabetic actions of thiazolidinediones,” Cell, vol. 148, pp. 556–567, 2012. View at Publisher · View at Google Scholar
  30. H. Li, Z. Gao, J. Zhang et al., “Sodium butyrate stimulates expression of fibroblast growth factor 21 in liver by inhibition of histone deacetylase 3,” Diabetes, vol. 61, pp. 797–806, 2012.
  31. F. M. Fisher, P. C. Chui, P. J. Antonellis et al., “Obesity is a fibroblast growth factor 21 (FGF21)-resistant state,” Diabetes, vol. 59, no. 11, pp. 2781–2789, 2010. View at Publisher · View at Google Scholar · View at Scopus